Alexander Nolte's Net Worth
$4.12 Thousand
Who is Alexander Nolte?
Alexander Nolte does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Syndax Pharmaceuticals Inc, and Oncorus, Inc..
SEC CIK
Alexander Nolte's CIK is 0001891979
Past Insider Trading and Trends
2022 was Alexander Nolte's most active year for acquiring shares with 2 total transactions. Alexander Nolte's most active month to acquire stocks was the month of January. 2022 was Alexander Nolte's most active year for disposing of shares, totalling 1 transactions. Alexander Nolte's most active month to dispose stocks was the month of January. 2023 saw Alexander Nolte paying a total of $485,350.00 for 17,000 shares, this is the most they've acquired in one year. In 2022 Alexander Nolte cashed out on 968 shares for a total of $16,117.20, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Syndax Pharmaceuticals Inc (SNDX) Snapshot price: $22.72
Chief Accounting Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
|
—
|
0
|
$14.52 | -$4,123.68 |
0
|
Jan 31 - Feb 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Oncorus, Inc. (ONCR) Snapshot price: $0.126
Interim CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||